Edit
INBRAIN NEUROELECTRONICS
http://www.inbrain-neuroelectronics.com/Last activity: 18.09.2025
Active
By using graphene, the thinnest material known to mankind, INBRAIN is developing smart brain interfaces that will improve the quality of life for millions of people around the world.
In Europe alone, up to 35 percent of the population is affected by brain disorders, causing not only considerable suffering but also costs of up to 800 billion euros per year. It is known that brain implants can be used to treat patients with epilepsy, Parkinson’s, and other brain related disease. However, existing interfaces are metal based with considerable restrictions for miniaturization and signal resolution, therefore limiting their therapeutic effect and causing side effects.
INBRAIN’s technology overcomes these shortcomings. The use of the revolutionary material graphene enables the design of a less invasive brain interface with nanoscale electrodes, decisively reducing side effects. The wireless system decodes brain signals with unprecedented ultra-high signal resolution. Through machine learning, the implant adapts to each individual patient, delivering personalized therapy.
In Europe alone, up to 35 percent of the population is affected by brain disorders, causing not only considerable suffering but also costs of up to 800 billion euros per year. It is known that brain implants can be used to treat patients with epilepsy, Parkinson’s, and other brain related disease. However, existing interfaces are metal based with considerable restrictions for miniaturization and signal resolution, therefore limiting their therapeutic effect and causing side effects.
INBRAIN’s technology overcomes these shortcomings. The use of the revolutionary material graphene enables the design of a less invasive brain interface with nanoscale electrodes, decisively reducing side effects. The wireless system decodes brain signals with unprecedented ultra-high signal resolution. Through machine learning, the implant adapts to each individual patient, delivering personalized therapy.
Total raised: $90.12M
Investors 2
| Date | Name | Website |
| - | Vsquared V... | vsquared.v... |
| - | Alta Life ... | altals.com... |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 09.05.2025 | Grant | $4.49M | - |
| 08.11.2024 | Series B | $50M | - |
| 20.12.2022 | - | $18.62M | - |
| 31.03.2021 | Series A | $17M | Alta Life ... |
Mentions in press and media 23
| Date | Title | Description |
| 18.09.2025 | Capital meets care: 10 venture capital firms transforming healthcare across Europe | Venture capital remains one of the cornerstones of Europe’s innovation landscape, fuelling the growth of startups across every sector. In our last list, we spotlighted 15 VC firms focused on sustainability, underlining how investors are sha... |
| 06.08.2025 | From lab to market: 10 of the most promising EU-funded HealthTech startups | HealthTech is one of Europe’s fastest-growing startup sectors, and EU funding is playing a major role in driving the next wave of innovation. From AI-powered diagnostics to smart medical devices, startups across the continent are tackling m... |
| 10.05.2025 | Redaptive's $650M Credit Facility: A Game Changer for Energy Efficiency | In a world where energy efficiency is king, Redaptive has just secured a throne. The Denver-based Energy-as-a-Service (EaaS) provider recently closed a monumental $650 million credit facility with CDPQ and Nuveen. This financial windfall is... |
| 09.05.2025 | Ethris Receives €10M EU4Health Grant | Ethris, a Munich, Germany-based clinical-stage biotechnology company, received a €10M grant from EU4Health. The company intends to allocate the amount of support NoVir, a comprehensive project including several preclinical and clinical stud... |
| 09.05.2025 | Inbrain Neuroelectronics Receives €4M Grant | Inbrain Neuroelectronics, a Barcelona, Spain-based clinical-stage neurotechnology company, received a €4M grant by the Spanish Ministry of Industry and Tourism through the PERTE Chip initiative. The company intends to allocate the amount to... |
| 08.11.2024 | INBRAIN Neuroelectronics: Brain-Computer Interface Therapeutics Company Raises $50 Million (Series B) | INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company developing graphene-based neural technologies, announced the closing of a $50 million Series B financing round. The funding round was led by imec.xpand with ... |
| 31.10.2024 | INBRAIN Neuroelectronics: Pioneering the Future of Brain-Computer Interfaces | In the world of neuroscience, a quiet revolution is brewing. INBRAIN Neuroelectronics, a Barcelona-based company, is at the forefront of this change. Recently, they secured $50 million in Series B funding, pushing their total capital raised... |
| 30.10.2024 | INBRAIN Neuroelectronics: Brain-Computer Interface Therapeutics Company Secures $50 Million (Series B) | INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company developing graphene-based neural technologies, announced the closing of a $50 million Series B funding round. The funding round was led by imec.xpand with ne... |
| 29.10.2024 | INBRAIN Neuroelectronics Raises $50M in Series B Funding | INBRAIN Neuroelectronics, a Barcelona, Spain-based brain-computer interface therapeutics (BCI-Tx) company, raised $50M in Series B funding. The round, which brought the total amount to $68M, was led by imec.xpand with new investors EIC Fund... |
| 08.08.2024 | EU-Startups Podcast | Episode 80: Benedikt von Schoeler, General Partner of Vsquared Ventures | In this episode, we catch up with Benedikt von Schoeler, General Partner of VSquared Ventures, a leading early-stage Deep Tech fund, backing some of Europe’s most promising Deep Tech companies, including Isar Aerospace, Zama, IQM Quantum, I... |
Show more